Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma

International Journal of Oncology

Volumn 45, Issue 2, 2014, Pages 710-718

  Lin, Cheng Wei ^a,b   Sun, Min Siou ^b   Wu, Han Chung ^b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

Epigenetic regulation; Human oral squamous cell carcinoma; Invasion; Metastasis; Podocalyxin like 1

Indexed keywords

CORTACTIN; CYTOKINE; DEOXYCYTIDINE; F ACTIN; FOCAL ADHESION KINASE; PAXILLIN; PODOCALYXIN; PODOCALYXIN LIKE 1 PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; SIALOGLYCOPROTEIN; SMALL INTERFERING RNA; TRANSCRIPTOME; TUMOR MARKER;

ANALYSIS; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL LINE; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; DOWN REGULATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FILOPODIUM; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; METASTASIS; METASTASIS INHIBITION; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; TUMOR INVASION; UPREGULATION; BIOSYNTHESIS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUTH TUMOR; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA METHYLATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIALOGLYCOPROTEINS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84902581844     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2427     Document Type: Article

References (53)

1. Chen YJ, Chang JT, Liao CT, et al: Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 99: 1507-1514, 2008.
2. Zygogianni AG, Kyrgias G, Karakitsos P, et al: Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol 3: 2, 2011.
3. Fina L, Molgaard HV, Robertson D, et al: Expression of the CD34 gene in vascular endothelial cells. Blood 75: 2417-2426, 1990. (Pubitemid 20202322)
4. Labastie MC, Cortes F, Romeo PH, Dulac C and Peault B: Molecular identity of hematopoietic precursor cells emerging in the human embryo. Blood 92: 3624-3635, 1998. (Pubitemid 28525188)
5. Kerjaschki D, Sharkey DJ and Farquhar MG: Identification and characterization of podocalyxin - the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 98: 1591-1596, 1984. (Pubitemid 14126988)
6. Doyonnas R, Nielsen JS, Chelliah S, et al: Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells. Blood 105: 4170-4178, 2005. (Pubitemid 40720759)
7. Nielsen JS and McNagny KM: The role of podocalyxin in health and disease. J Am Soc Nephrol 20: 1669-1676, 2009.
8. Economou CG, Kitsiou PV, Tzinia AK, et al: Enhanced podocalyxin expression alters the structure of podocyte basal surface. J Cell Sci 117: 3281-3294, 2004. (Pubitemid 39139913)
9. Sizemore S, Cicek M, Sizemore N, Ng KP and Casey G: Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res 67: 6183-6191, 2007. (Pubitemid 47037499)
10. Hsu YH, Lin WL, Hou YT, et al: Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7. Am J Pathol 176: 3050-3061, 2010.
11. Schmieder S, Nagai M, Orlando RA, Takeda T and Farquhar MG: Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. J Am Soc Nephrol 15: 2289-2298, 2004. (Pubitemid 39159329)
12. Doyonnas R, Kershaw DB, Duhme C, et al: Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med 194: 13-27, 2001. (Pubitemid 32660434)
13. Forse CL, Yilmaz YE, Pinnaduwage D, et al: Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancer. Breast Cancer Res Treat 137: 709-719, 2013.
14. Binder ZA, Siu IM, Eberhart CG, et al: Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome. PLoS One 8: e75945, 2013.
15. Boman K, Larsson AH, Segersten U, et al: Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer. Br J Cancer 108: 2321-2328, 2013.
16. Larsson A, Johansson ME, Wangefjord S, et al: Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. Br J Cancer 105: 666-672, 2011.
17. Chen QW, Zhu XY, Li YY and Meng ZQ: Epigenetic regulation and cancer (Review). Oncol Rep 31: 523-532, 2014.
18. Jithesh PV, Risk JM, Schache AG, et al: The epigenetic landscape of oral squamous cell carcinoma. Br J Cancer 108: 370-379, 2013.
19. Huang TT, Gonzales CB, Gu F, et al: Epigenetic deregulation of the anaplastic lymphoma kinase gene modulates mesenchymal characteristics of oral squamous cell carcinomas. Carcinogenesis 34: 1717-1727, 2013.
20. Towle R, Truong D, Hogg K, Robinson WP, Poh CF and Garnis C: Global analysis of DNA methylation changes during progression of oral cancer. Oral Oncol 49: 1033-1042, 2013.
21. Hong Y, Downey T, Eu KW, Koh PK and Cheah PY: A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis 27: 83-90, 2010.
22. Kaiser S, Park YK, Franklin JL, et al: Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 8: R131, 2007.
23. Ki DH, Jeung HC, Park CH, et al: Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 121: 2005-2012, 2007.
24. Sabates-Bellver J, Van der Flier LG, de Palo M, et al: Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5: 1263-1275, 2007.
25. Skrzypczak M, Goryca K, Rubel T, et al: Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One 5: pii: e13091, 2010.
26. Cho JY, Lim JY, Cheong JH, et al: Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res 17: 1850-1857, 2011.
27. D'Errico M, de Rinaldis E, Blasi MF, et al: Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer 45: 461-469, 2009.
28. Wang Q, Wen YG, Li DP, et al: Upregulated INHBA expression is associated with poor survival in gastric cancer. Med Oncol 29: 77-83, 2012.
29. Chen X, Cheung ST, So S, et al: Gene expression patterns in human liver cancers. Mol Biol Cell 13: 1929-1939, 2002. (Pubitemid 34651483)
30. Mas VR, Maluf DG, Archer KJ, et al: Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med 15: 85-94, 2009.
31. Roessler S, Jia HL, Budhu A, et al: A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res 70: 10202-10212, 2010.
32. Wurmbach E, Chen YB, Khitrov G, et al: Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45: 938-947, 2007. (Pubitemid 46646500)
33. Su H, Hu N, Yang HH, et al: Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res 17: 2955-2966, 2011.
34. Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB and Lowe AW: Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology 131: 925-933, 2006. (Pubitemid 44307058)
35. Hu N, Clifford RJ, Yang HH, et al: Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. BMC Genomics 11: 576, 2010.
36. Kim SM, Park YY, Park ES, et al: Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS One 5: e15074, 2010.
37. Kimchi ET, Posner MC, Park JO, et al: Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res 65: 3146-3154, 2005. (Pubitemid 40524595)
38. Cromer A, Carles A, Millon R, et al: Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23: 2484-2498, 2004. (Pubitemid 38520746)
39. Ginos MA, Page GP, Michalowicz BS, et al: Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 64: 55-63, 2004. (Pubitemid 38114082)
40. Schlingemann J, Habtemichael N, Ittrich C, et al: Patient-based cross-platform comparison of oligonucleotide microarray expression profiles. Lab Invest 85: 1024-1039, 2005. (Pubitemid 41486427)
41. Sengupta S, den Boon JA, Chen IH, et al: Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res 66: 7999-8006, 2006. (Pubitemid 44299164)
42. Toruner GA, Ulger C, Alkan M, et al: Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet 154: 27-35, 2004. (Pubitemid 39286169)
43. Murphy DA and Courtneidge SA: The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol 12: 413-426, 2011.
44. Sung BH, Zhu X, Kaverina I and Weaver AM: Cortactin controls cell motility and lamellipodial dynamics by regulating ECM secretion. Curr Biol 21: 1460-1469, 2011.
45. Oser M, Yamaguchi H, Mader CC, et al: Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J Cell Biol 186: 571-587, 2009.
46. Clark ES, Whigham AS, Yarbrough WG and Weaver AM: Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 67: 4227-4235, 2007. (Pubitemid 46815069)
47. Dallas MR, Chen SH, Streppel MM, Sharma S, Maitra A and Konstantopoulos K: Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells. Am J Physiol Cell Physiol 303: C616-C624, 2012.
48. Thomas SN, Schnaar RL and Konstantopoulos K: Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells. Am J Physiol Cell Physiol 296: C505-C513, 2009.
49. Su PF, Huang WL, Wu HT, Wu CH, Liu TY and Kao SY: p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner. Oral Oncol 46: 734-739, 2010.
50. Alyasiri NS, Ali A, Kazim Z, et al: Aberrant promoter methylation of PTEN gene among Indian patients with oral squamous cell carcinoma. Int J Biol Markers 28: 298-302, 2013.
51. Viswanathan M, Tsuchida N and Shanmugam G: Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 105: 41-46, 2003. (Pubitemid 36418483)
52. Butta N, Larrucea S, Alonso S, et al: Role of transcription factor Sp1 and CpG methylation on the regulation of the human podocalyxin gene promoter. BMC Mol Biol 7: 17, 2006.
53. Cao YX, Jean JC and Williams MC: Cytosine methylation of an Sp1 site contributes to organ-specific and cell-specific regulation of expression of the lung epithelial gene t1alpha. Biochem J 350: 883-890, 2000.